Investigators searched publication databases for randomized controlled trials evaluating cognitive training and remediation interventions among patients with MDD.
Your search for major depressive disorder returned 11 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
Better baseline cardiovascular health and improvement in cardiovascular health over seven years tied to lower 19-year risk for depression
The Alpha-Stim-D trial was a noncommercial, multicenter, randomly assigned, parallel group, double-blind trial conducted at 25 primary care practices in the United Kingdom.
Authors say findings similar across people with schizophrenia, major depressive disorder, and bipolar disorder in three distinct geographic settings
Patients who had treatment-naïve MDD were recruited in the US between 2007 and 2013 for the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) study.
Researchers sought to evaluate the relationship among insomnia symptoms, inflammation, and risk for stroke.
Researcher sought to assess how timing, frequency, and maintenance of physical activity in adulthood, over the span of 30 years, is associated with cognitive function later in life.
Solanezumab is a humanized monoclonal antibody designed to increase clearance of soluble amyloid beta (Aβ) from the brain by binding to aggregated forms of Aβ.
According to a new poll, more than 90% of adults who reported they get good sleep were also free of depressive symptoms.
Being physically active at any point during adulthood is associated with a higher later-life cognitive state.
Inpatients with schizophrenia spectrum disorders were randomly assigned to receive treatment as usual with or without a yoga-based group intervention for 4 weeks.
Latest News Your top articles for WednesdayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses